JURISICA; IGOR

Patent Applications and Registrations

Patent applications and USPTO patent grants for JURISICA; IGOR.The latest application filed is for "methods for use of cdx2 as a biomarker to guide use of autophagy inhibitors in ovarian cancer".

Company Profile

0.5.17

JURISICA; IGOR - TORONTO CA
Jurisica; Igor - Richmond Hill CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Use Of Cdx2 As A Biomarker To Guide Use Of Autophagy Inhibitors In Ovarian Cancer App 20210215710 - JURISICA; IGOR ; et al.	2021-07-15
Prognostic And Predictive Gene Signature For Non-small Cell Lung Cancer And Adjuvant Chemotherapy App 20160032407 - Tsao; Ming-Sound ; et al.	2016-02-04
Prognostic and Predictive Gene Signature for Non-Small Cell Lung Cancer and Adjuvant Chemotherapy App 20160024596 - Tsao; Ming-Sound ; et al.	2016-01-28
Prognostic Signature For Oral Squamous Cell Carcinoma App 20130303826 - Jurisica; Igor ; et al.	2013-11-14
Scalable scheduling of tasks in heterogeneous systems Grant 8,434,085 - Cialini , et al. April 30, 2	2013-04-30
Compositions And Methods For Classifying Lung Cancer And Prognosing Lung Cancer Survival App 20130065789 - Tsao; Ming-Sound ; et al.	2013-03-14
Prognostic And Predictive Gene Signature For Non-small Cell Lung Cancer And Adjuvant Chemotherapy App 20120323594 - Tsao; Ming-Sound ; et al.	2012-12-20
Lsc And Hsc Signatures For Predicting Survival Of Patients Having Hematological Cancer App 20120237488 - Dick; John ; et al.	2012-09-20
Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy Grant 8,211,643 - Tsao , et al. July 3, 2	2012-07-03
Methods And Compositions For Lung Cancer Prognosis App 20120141603 - Tsao; Ming-Sound ; et al.	2012-06-07
Prognostic Gene Expression Signature For Squamous Cell Carcinoma Of The Lung App 20120100999 - Tsao; Ming-Sound ; et al.	2012-04-26
Methods For Biomarker Identification And Biomarker For Non-small Cell Lung Cancer App 20120004116 - Tsao; Ming-Sound ; et al.	2012-01-05
Materials and methods for prognosing lung cancer survival Grant 8,026,055 - Tsao , et al. September 27, 2	2011-09-27
Compositions And Methods For Classifying Lung Cancer And Prognosing Lung Cancer Survival App 20110224313 - Tsao; Ming-Sound ; et al.	2011-09-15
Prognostic And Predictive Gene Signature For Non-small Cell Lung Cancer And Adjuvant Chemotherapy App 20100184063 - Tsao; Ming-Sound ; et al.	2010-07-22
Prognostic and Predictive Gene Signature for Non-Small Cell Lung Cancer and Adjuvant Chemotherapy App 20090291448 - Jurisica; Igor ; et al.	2009-11-26
Scalable Scheduling of Tasks in Heterogeneous Systems App 20090282413 - Cialini; Enzo ; et al.	2009-11-12
Materials And Methods For Prognosing Lung Cancer Survival App 20080176236 - Tsao; Ming Sound ; et al.	2008-07-24
Dynamic semi-structured repository for mining software and software-related information Grant 6,339,776 - Dayani-Fard , et al. January 15, 2	2002-01-15
Dynamic Semi-structured Repository For Mining Software And Software-related Information App 20010042067 - DAYANI-FARD, HOMAYOUN ; et al.	2001-11-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.